Published in Lancet on November 22, 1986
Effects of withdrawing erythropoietin. BMJ (1991) 2.19
Hematopoietic growth factors. J Clin Invest (1987) 2.11
Mechanisms of anemia in CKD. J Am Soc Nephrol (2012) 1.91
Development and characterization of novel erythropoiesis stimulating protein (NESP). Br J Cancer (2001) 1.72
Anti-erythropoietin antibodies followed by endogenous erythropoietin production in a dialysis patient. Pediatr Nephrol (2010) 1.39
Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis. Br Med J (Clin Res Ed) (1987) 1.23
Role of Gas6 in erythropoiesis and anemia in mice. J Clin Invest (2008) 1.16
Assessment of pain after subcutaneous injection of erythropoietin in patients receiving haemodialysis. BMJ (1991) 1.14
Anaemia management and mortality risk in chronic kidney disease. Nat Rev Nephrol (2013) 1.06
Anaemia of rheumatoid arthritis: serum erythropoietin concentrations and red cell distribution width in relation to iron status. Ann Rheum Dis (1990) 1.05
Erythropoietin: the developing story. Br Med J (Clin Res Ed) (1988) 1.05
Effects of erythropoietin on muscle O2 transport during exercise in patients with chronic renal failure. J Clin Invest (1996) 0.97
Recombinant erythropoietin in clinical practice. Postgrad Med J (2003) 0.92
HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond. Nat Rev Nephrol (2015) 0.92
The effects of kidney-disease-related loss on long-term dialysis patients' depression and quality of life: positive affect as a mediator. Clin J Am Soc Nephrol (2008) 0.90
The pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects. Br J Clin Pharmacol (1990) 0.90
A review of the first year of Medicare coverage of erythropoietin. Health Care Financ Rev (1994) 0.89
Anemia in children with chronic kidney disease. Pediatr Nephrol (2007) 0.89
A Safe and Easy Introduction of Darbepoetin-Alpha in Patients Receiving Maintenance Hemodialysis and Epoetin Monotherapy: A "Half-and-Half" Combination Therapy. Curr Ther Res Clin Exp (2013) 0.87
Cisplatin-associated anemia: an erythropoietin deficiency syndrome. J Clin Invest (1995) 0.86
Clinical experience with darbepoietin alfa (NESP) in children undergoing hemodialysis. Pediatr Nephrol (2004) 0.82
Stimulating erythropoiesis in inflammatory bowel disease associated anemia. World J Gastroenterol (2007) 0.81
The use of erythropoietin in renal failure. Postgrad Med J (1991) 0.80
Epoetin Theta with a New Dosing Schedule in Anaemic Cancer Patients Receiving Nonplatinum-Based Chemotherapy: A Randomised Controlled Trial. Arch Drug Inf (2011) 0.79
Structural identification of modified amino acids on the interface between EPO and its receptor from EPO BRP, human recombinant erythropoietin by LC/MS analysis. Mol Cells (2014) 0.79
The influence of the pleiotropic action of erythropoietin and its derivatives on nephroprotection. Med Sci Monit (2013) 0.79
Epoetin Theta in Anaemic Cancer Patients Receiving Platinum-Based Chemotherapy: A Randomised Controlled Trial. Arch Drug Inf (2010) 0.79
Use of agents stimulating erythropoiesis in digestive diseases. World J Gastroenterol (2009) 0.79
Polymorphisms in two genes, IL-1B and ACE, are associated with erythropoietin resistance in Korean patients on maintenance hemodialysis. Exp Mol Med (2008) 0.79
Bench to bedside: A role for erythropoietin in sepsis. Crit Care (2010) 0.79
Recombinant human epoetin beta in the treatment of renal anemia. Ther Clin Risk Manag (2007) 0.78
Designing a Long Acting Erythropoietin by Fusing Three Carboxyl-Terminal Peptides of Human Chorionic Gonadotropin β Subunit to the N-Terminal and C-Terminal Coding Sequence. Int J Cell Biol (2011) 0.78
Endotoxaemia in haemodialysis: a novel factor in erythropoetin resistance? PLoS One (2012) 0.78
Parathyroidectomy for hyperparathyroidism associated with renal disease. Ann R Coll Surg Engl (1995) 0.78
The effect of intravenous ascorbic acid in hemodialysis patients with normoferritinemic anemia. Kidney Res Clin Pract (2012) 0.77
The predictive parameters of erythropoietin hyporesponsiveness in patients on continuous ambulatory peritoneal dialysis. Korean J Intern Med (2001) 0.77
Erythropoietin prevents endothelial dysfunction in GTP-cyclohydrolase I-deficient hph1 mice. J Cardiovasc Pharmacol (2014) 0.77
Population pharmacokinetics of darbepoetin alfa in haemodialysis and peritoneal dialysis patients after intravenous administration. Br J Clin Pharmacol (2006) 0.76
Population pharmacokinetics of darbepoetin alpha in peritoneal dialysis and non-dialysis patients with chronic kidney disease after single subcutaneous administration. Eur J Clin Pharmacol (2008) 0.76
Erythropoietin in sepsis: a new use for a familiar drug? Crit Care Med (2009) 0.76
Safety and the therapeutic protein products made by genetic engineering. Br Med J (Clin Res Ed) (1988) 0.75
Nephrology, dialysis and transplantation. Postgrad Med J (1993) 0.75
Nephrology, dialysis and transplantation. Postgrad Med J (1990) 0.75
Resistance to recombinant human erythropoietin due to aluminium overload and its reversal by low dose desferrioxamine therapy. Postgrad Med J (1993) 0.75
The use of erythropoietin in a Jehovah's Witness undergoing major surgery and chemotherapy. Br J Cancer (1991) 0.75
Effect of erythropoiesis-stimulating agents on blood pressure in pre-dialysis patients. PLoS One (2013) 0.75
Erythropoietin has a restorative effect on the contractility of arteries following experimental hypoxia. J Cardiovasc Dis Res (2013) 0.75
Changes in determinants of blood rheology during treatment with haemodialysis and recombinant human erythropoietin. BMJ (1990) 0.75
Efficacy & safety of continuous erythropoietin receptor activator (CERA) in treating renal anaemia in diabetic patients with chronic kidney disease not on dialysis. Indian J Med Res (2014) 0.75
Erythropoietin: from bench to bedside. Trans Am Clin Climatol Assoc (1991) 0.75
Haematology. Postgrad Med J (1990) 0.75
Influence on erythropoietin levels of treatment with cisplatinum-endoxan. Arch Gynecol Obstet (1992) 0.75
Low versus high dose erythropoiesis-stimulating agents in hemodialysis patients with anemia: A randomized clinical trial. PLoS One (2017) 0.75
Effects of azathioprine on response of renal anaemia to subcutaneous recombinant human erythropoietin. J Clin Pathol (1993) 0.75
Long-term effects of oral L-carnitine supplementation on anemia in chronic hemodialysis. Cardiorenal Med (2014) 0.75
Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med (1987) 5.57
Experience with human growth hormone in Great Britain: the report of the MRC Working Party. Clin Endocrinol (Oxf) (1979) 4.42
Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet (1987) 4.20
Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med (1985) 2.46
Comparison of multilocus sequence typing and pulsed-field gel electrophoresis as tools for typing Staphylococcus aureus isolates in a microepidemiological setting. J Clin Microbiol (2002) 2.45
Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Ann Intern Med (1989) 2.43
Formation of glycogen in the liver of anaesthetized cats with notes on specific action. J Physiol (1936) 2.39
The adrenals and anaesthetic hyperglycaemia. J Physiol (1933) 2.23
Isolated systolic hypertension and subclinical cardiovascular disease in the elderly. Initial findings from the Cardiovascular Health Study. JAMA (1992) 2.21
Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer (1999) 2.19
Does colchicine work? The results of the first controlled study in acute gout. Aust N Z J Med (1987) 2.17
Seromuscular colocystoplasty lined with urothelium: experience with 16 patients. Urology (1995) 2.06
Consultant appraisal. QJM (2001) 2.03
Hypertension, diuretics and breast cancer risk. J Hum Hypertens (2006) 1.90
Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure. Lancet (1974) 1.80
Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. Respiration (2011) 1.78
Mutation analysis of the entire PKD1 gene: genetic and diagnostic implications. Am J Hum Genet (2000) 1.78
High incidence of end-stage renal disease in Indo-Asians in the UK. QJM (1995) 1.68
Hypoechoic plaque at US of the carotid artery: an independent risk factor for incident stroke in adults aged 65 years or older. Cardiovascular Health Study. Radiology (1998) 1.68
Clinical observations on the effects of debrisoquine sulphate in patients with high blood-pressure. Br Med J (1966) 1.67
Iron absorption and loading in beta-thalassaemia intermedia. Lancet (1979) 1.66
Insulin resistance and substrate utilization in human endotoxemia. J Clin Endocrinol Metab (2000) 1.66
Effect of sunlight and season on serotonin turnover in the brain. Lancet (2002) 1.63
The international reference preparation of erythropoietin. Bull World Health Organ (1966) 1.60
Studies on the movements of the alimentary canal: I. The effects of electrolytes on the rhythmical contractions of the isolated mammalian intestine. J Physiol (1927) 1.59
Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes. Leukemia (2002) 1.59
National audit of emergency department child protection procedures. Emerg Med J (2003) 1.58
Cancer in patients receiving dialysis. Br Med J (1980) 1.52
The prevalence of isolated systolic hypertension in patients 60 years of age and over attending Australian general practitioners. Blood Press (1998) 1.50
Prevention of iron loading in transfusion-dependent thalassaemia. Lancet (1978) 1.47
Medical school admissions, specialty selection, and distribution of physicians. JAMA (1976) 1.44
A single dose of citalopram increases fear recognition in healthy subjects. J Psychopharmacol (2007) 1.43
Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component. Lancet (1991) 1.42
Rapidly progressive glomerulonephritis: what should be first-line therapy? Nephron (1994) 1.42
In vivo studies on the relationship between intestinal iron (Fe3+) absorption, hypoxia and erythropoiesis in the mouse. Br J Haematol (1988) 1.39
Late renal failure due to prostatic outflow obstruction: a preventable disease. BMJ (1989) 1.38
Objective monitoring of activity in Wegener's granulomatosis by measurement of serum C-reactive protein concentration. Clin Nephrol (1984) 1.36
Plasma ferritin determination as a diagnostic tool. West J Med (1986) 1.34
Selection conditions affect the evolution of specific mutations in the reverse transcriptase gene associated with resistance to DMP 266. AIDS (1996) 1.34
Impact of a standard medication chart on prescribing errors: a before-and-after audit. Qual Saf Health Care (2009) 1.33
Clinical importance of acquired cystic disease of the kidney in patients undergoing dialysis. Br Med J (Clin Res Ed) (1983) 1.33
The effect of covertly manipulating the energy density of mixed diets on ad libitum food intake in 'pseudo free-living' humans. Int J Obes Relat Metab Disord (1998) 1.29
Iron metabolism in haemodialysis patients. A study of the management of iron therapy and overload. Q J Med (1979) 1.28
Late referral for maintenance dialysis. Br Med J (Clin Res Ed) (1984) 1.25
Community perspectives on care options for HIV prevention trial participants. AIDS Care (2007) 1.22
Primary structure of human prethrombin 2 and alpha-thrombin. J Biol Chem (1977) 1.21
Systemic amyloidosis of beta 2-microglobulin type: a complication of long-term haemodialysis. J Clin Pathol (1987) 1.21
Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen. J Immunol Methods (1987) 1.21
Identification of mutations in the duplicated region of the polycystic kidney disease 1 gene (PKD1) by a novel approach. Am J Hum Genet (1997) 1.21
Communication skills training for emergency department senior house officers--a qualitative study. J Accid Emerg Med (2000) 1.21
USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patients. Contrib Nephrol (1989) 1.20
Immunoreactive erythropoietin in serum. I. Evidence for the validity of the assay method and the physiological relevance of estimates. Br J Haematol (1982) 1.19
A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis. Br J Dermatol (2003) 1.17
Molecular cloning and analysis of genes for sialic acid synthesis in Neisseria meningitidis group B and purification of the meningococcal CMP-NeuNAc synthetase enzyme. J Bacteriol (1994) 1.17
Effect of treatment with biological agents for arthritis in Australia: the Australian Rheumatology Association Database. Intern Med J (2007) 1.15
Objective monitoring of disease activity in polyarteritis by measurement of serum C reactive protein concentration. Br Med J (Clin Res Ed) (1984) 1.14
Noxytiolin and peritoneal adhesion formation. Br J Surg (1976) 1.14
Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3. Q J Med (1984) 1.13
Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin. Br Med J (Clin Res Ed) (1985) 1.12
Human prothrombin activation. J Biol Chem (1975) 1.12
Nonfatal clinical presentation of elephant endotheliotropic herpes virus discovered in a group of captive Asian elephants (Elephas maximus). J Zoo Wildl Med (2010) 1.11
Graft adaptation: studies on possible mechanisms in long-term surviving rat renal allografts. Transplantation (1980) 1.10
Absence of bacterial resistance to povidone iodine. J Clin Pathol (1976) 1.10
Serum sickness and acute renal failure after streptokinase therapy for myocardial infarction. Clin Exp Immunol (1990) 1.09
Preexisting human anti-murine immunoglobulin reactivity due to polyclonal rheumatoid factors. Cancer Res (1987) 1.07
Iron overload in mild sideroblastic anaemias. Lancet (1983) 1.06
Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450. Chem Biol (1996) 1.06
Ferrioxamine excretion in iron-loaded man. Blood (1982) 1.06
The effect of erythroid hyperplasia on iron balance. Blood (1988) 1.06
Pharmacokinetics and clinical efficacy of long-term epidural ropivacaine infusion in children. Br J Anaesth (2000) 1.05
Development of the immune response in the foetal and newborn rhesus monkey. I. Response to bovine serum albumin. Immunology (1966) 1.05
Microcytosis, iron deficiency, and thalassaemia in preschool children. Arch Dis Child (1990) 1.05
Immunological factors and risk of infection in plateau phase myeloma. J Clin Pathol (1995) 1.05
Functional evaluation of the results of hypospadias surgery with uroflowmetry. J Urol (1995) 1.04
Simple method for early detection of peritonitis in patients on continuous ambulatory peritoneal dialysis. Lancet (1980) 1.04
Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma. Br J Dermatol (2005) 1.03
Collaborative study of estimates by radioimmunoassay of insulin concentrations in plasma samples examined in groups of five or six laboratories. J Endocrinol (1969) 1.03
Imaging of human colon cancer cells using He-Ion scanning microscopy. J Microsc (2010) 1.02
A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat (2003) 1.02
Renal complications of jejuno-ileal bypass for obesity. QJM (2001) 1.02
Studies on the interaction of rheumatoid factor with monosodium urate crystals and case report of coexistent tophaceous gout and rheumatoid arthritis. Ann Rheum Dis (1985) 1.01
Covert manipulation of energy density of high carbohydrate diets in 'pseudo free-living' humans. Int J Obes Relat Metab Disord (1998) 1.01
Comparison of the inhibition of thrombin by three plasma protease inhibitors. Biochemistry (1978) 1.01
Vein allografts for arterial replacement in rats: an immunological and histological study. Transplantation (1979) 1.01
Insulin and the storage of liver glycogen in anaesthetized cats. J Physiol (1936) 1.00
The safety of epoetin-alpha: results of clinical trials in the United States. Contrib Nephrol (1991) 0.99
Treatment of aggressive idiopathic membranous glomerulonephritis. Q J Med (1994) 0.99
Serum erythropoietin in humans at high altitude and its relation to plasma renin. J Appl Physiol (1985) (1985) 0.99
Acute interstitial nephritis and erythroderma associated with diflunisal. Br Med J (1980) 0.99
Clinical usefulness of urinary 3-methylhistidine excretion in indicating muscle protein breakdown. Br Med J (Clin Res Ed) (1981) 0.98
Pixellated Cd(Zn)Te high-energy X-ray instrument. J Instrum (2011) 0.98
The safety of recombinant factor VIIa in cardiac surgery. Anaesth Intensive Care (2010) 0.98
The swarming of proteus on semisynthetic media. J Med Microbiol (1971) 0.98
Integration of e-learning resources into a medical school curriculum. Med Teach (2011) 0.98